Spearheaded by the UK DRI and Health Data Research UK (HDR UK), the Dementia Trials Accelerator aims to drastically increase the number of people in the UK participating in late-stage clinical trials for dementia. Trials will be extended to community settings, making participation more accessible than ever, and ensuring access to promising new treatments for many more people.
The DTA is now recruiting its first participants via the REACT cohort. Find out more about this here. Please visit Join Dementia Research for other opportunities to get involved in research.
The Accelerator, supported by the government’s Dame Barbara Windsor Dementia Goals programme (formerly known as the Dame Barbara Windsor Dementia Mission) and funded by the Medical Research Council (MRC), aims to rapidly identify a large group of people who are at risk of or diagnosed with early-stage dementia.
This will boost opportunities for these people to participate in research – offering them the chance to receive potentially life-changing new treatments as part of a clinical trial.
Latest updates
